GENERAL ATLANTIC, L.P.
Follow13F filer, CIK 1017645, New York, NY
GENERAL ATLANTIC, L.P. reported $2,480,711,056 across 12 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 98.13% of the portfolio.
Accepted , ingested 13F-HR 0000950142-26-003038
- Period
- 2026-09-30
- Reported value
- $2.48B
- Holdings
- 12
- Top 10 weight
- 98.13%
- New
- 1
- Sold out
- 1
Part of the filer group GENERAL ATLANTIC, L.P.
General Atlantic Cooperatief, L.P.General Atlantic Cooperatief U.A.
- General Atlantic Cooperatief, L.P.
- General Atlantic Cooperatief U.A.
- General Atlantic (DLO), L.P.
- General Atlantic DO B.V.
- General Atlantic GenPar (Bermuda), L.P.
- General Atlantic GenPar, L.P.
- General Atlantic GenPar (Lux) SCSp
- General Atlantic (Lux) S.a r.l.
- General Atlantic Partners 100, L.P.
- General Atlantic Partners (Bermuda) EU, L.P.
- General Atlantic Partners (Bermuda) IV, L.P.
- General Atlantic Partners (Lux) SCSp
- General Atlantic PH B.V.
- General Atlantic RK B.V.
- General Atlantic (SPV) GP, LLC
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| KRSAnew | +1,366,242 | $43.7M |
| RSKDadded | +5,324,998 | $42.1M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PHVSreduced | -4,899,267 | -$155M |
| DLOreduced | -9,842,559 | -$135M |
| RVMDexited | -357,791 | -$67M |
| CHYMreduced | -2,333,056 | -$62.2M |
| XPreduced | -2,607,180 | -$54.7M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0000950142-26-003038, largest first. % of portfolio is the value over $2,480,711,056, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| DLODLOCAL LTD | 36,814,136 | $507M | 20.42% | -9,842,559 | 2026-11-17, 13D/A: 24,000,957 shares, 13.4% of the class, 13D/A filed 2026-11-19 | Timeline | |
| CHYMCHIME FINL INC | 18,926,627 | $504M | 20.33% | -2,333,056 | Timeline | ||
| LFTOLIFTOFF MOBILE INC | 25,315,646 | $400M | 16.12% | 0 | Timeline | ||
| XPXP INC | 17,958,953 | $377M | 15.2% | -2,607,180 | Timeline | ||
| ALKTALKAMI TECHNOLOGY INC | 19,379,038 | $265M | 10.69% | 0 | Timeline | ||
| SPTXSEAPORT THERAPEUTICS INC | 6,101,582 | $123M | 4.96% | 0 | Timeline | ||
| RSKDRISKIFIED LTD | 10,649,996 | $84.2M | 3.4% | +5,324,998 | Timeline | ||
| NRIXNURIX THERAPEUTICS INC | 3,032,185 | $71.9M | 2.9% | 0 | Timeline | ||
| PHVSPHARVARIS N V | 1,651,490 | $52.4M | 2.11% | -4,899,267 | Timeline | ||
| PBLSPARABILIS MEDICINES INC | 1,538,461 | $49.7M | 2% | 0 | Timeline | ||
| KRSAKORSANA BIOSCIENCES INC | 1,366,242 | $43.7M | 1.76% | new | Timeline | ||
| GROVGROVE COLLABORATIVE HOLD INC | 2,474,859 | $2.62M | 0.11% | 0 | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 357,791 | $67M | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950142-26-003038 | base | 2026-11-13 |